Fingerprint
Dive into the research topics of 'Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
and Japan RCC Trialist Collaborative Group (JRTCG) investigators
Research output: Contribution to journal › Article › peer-review
11
Citations
(Scopus)